T A Medsger Selected Research

Penicillamine (Cuprimine)

10/2006	Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study.
6/2001	Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial.
3/2001	The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial.
1/2001	D-penicillamine in systemic sclerosis? Yes!
11/2000	Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

T A Medsger Research Topics

Disease

8	Systemic Scleroderma (Systemic Sclerosis) 07/2001 - 05/2000
4	Diffuse Scleroderma (Progressive Systemic Sclerosis) 10/2006 - 01/2000
2	Pain (Aches) 01/2001 - 03/2000
2	Dyspnea (Shortness of Breath) 03/2000 - 02/2000
2	Pulmonary Hypertension 03/2000 - 01/2000
1	Arthritis (Polyarthritis) 03/2001
1	Wounds and Injuries (Trauma) 01/2001
1	Contracture 11/2000
1	Hypertension (High Blood Pressure) 10/2000
1	Pneumothorax 03/2000
1	Fatigue 03/2000
1	Hemorrhage 03/2000
1	Anorexia 03/2000
1	Nausea 03/2000
1	digital ulcers 03/2000
1	Raynaud Disease (Raynaud's Disease) 03/2000
1	Sepsis (Septicemia) 03/2000
1	Cellulitis 03/2000
1	Pulmonary Arterial Hypertension 02/2000

Drug/Important Bio-Agent (IBA)

5	Penicillamine (Cuprimine)FDA Link 10/2006 - 11/2000
3	ametantrone (HAQ)IBA 10/2006 - 11/2000
2	trioctyl phosphine oxide (TOPO)IBA 07/2001 - 06/2000
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 07/2001 - 06/2000
2	Pharmaceutical PreparationsIBA 03/2001 - 11/2000
2	AutoantibodiesIBA 06/2000 - 05/2000
1	CreatinineIBA 03/2001
1	SmokeIBA 01/2001
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2000
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2000
1	CytokinesIBA 06/2000
1	HLA-DR Antigens (HLA-DR)IBA 05/2000
1	AntibodiesIBA 05/2000
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 05/2000
1	fibrillarinIBA 05/2000
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 03/2000
1	Carbon MonoxideIBA 02/2000

Therapy/Procedure

1	Surgical Amputation (Amputations) 01/2001
1	Debridement 01/2001
1	Sympathectomy (Sympathectomies) 01/2001
1	Therapeutics 03/2000
1	Plasma Exchange 01/2000